Condition: Monkeypox · Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.
This description comes directly from the study's public registry record.
Beatriz Mothe, PhD, MD · 676142408 · bmothe@irsicaixa.es
Susana Benet, PhD, MD · 676142408 · sbenet@lluita.org
Always discuss trial participation with your own doctor first.
| Germans Trias i Pujol Hospital | Badalona, Barcelona, Spain | Recruiting |
| BCN Checkpoint | Barcelona, Barcelona, Spain | Recruiting |
| VALLE HEBRÓN HOSPITAL/Centro Salud Internacional y Enfermedades Transmisibles Drassanes | Barcelona, Barcelona, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05562323